Kendall David M 4
4 · MANNKIND CORP · Filed Jul 31, 2019
Insider Transaction Report
Form 4
MANNKIND CORPMNKD
Kendall David M
Chief Medical Officer
Transactions
- Purchase
Common Stock, $0.01 Par Value
2019-07-31$0.95/sh+5,000$4,750→ 49,850 total
Footnotes (1)
- [F1]The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2019 representing the maximum allowable under the Plan for this period.